BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26826307)

  • 21. Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.
    Han HD; Byeon Y; Kang TH; Jung ID; Lee JW; Shin BC; Lee YJ; Sood AK; Park YM
    Int J Nanomedicine; 2016; 11():5729-5742. PubMed ID: 27843314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
    Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
    J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination.
    Mittal A; Schulze K; Ebensen T; Weissmann S; Hansen S; Guzmán CA; Lehr CM
    J Control Release; 2015 May; 206():140-52. PubMed ID: 25795506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
    Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
    Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
    Ma W; Chen M; Kaushal S; McElroy M; Zhang Y; Ozkan C; Bouvet M; Kruse C; Grotjahn D; Ichim T; Minev B
    Int J Nanomedicine; 2012; 7():1475-87. PubMed ID: 22619507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant.
    Zhang Y; Gu P; Wusiman A; Xu S; Ni H; Qiu T; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2020; 15():5527-5543. PubMed ID: 32848386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLGA nanoparticles enhance the expression of retinaldehyde dehydrogenase enzymes in dendritic cells and induce FoxP3(+) T-cells in vitro.
    Keijzer C; Spiering R; Silva AL; van Eden W; Jiskoot W; Vervelde L; Broere F
    J Control Release; 2013 May; 168(1):35-40. PubMed ID: 23500056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines.
    Xu P; Tang S; Jiang L; Yang L; Zhang D; Feng S; Zhao T; Dong Y; He W; Wang R; Zhang J; Liang Z
    J Control Release; 2016 Mar; 225():252-68. PubMed ID: 26826303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen.
    De Temmerman ML; Rejman J; Vandenbroucke RE; De Koker S; Libert C; Grooten J; Demeester J; Gander B; De Smedt SC
    J Control Release; 2012 Mar; 158(2):233-9. PubMed ID: 22063002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
    Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S
    J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response.
    Fischer S; Schlosser E; Mueller M; Csaba N; Merkle HP; Groettrup M; Gander B
    J Drug Target; 2009 Sep; 17(8):652-61. PubMed ID: 19622019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.
    Khademi F; Sahebkar A; Fasihi-Ramandi M; Taheri RA
    APMIS; 2018 Jun; 126(6):509-514. PubMed ID: 29924445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
    Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W
    J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
    Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
    Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
    Silva AL; Rosalia RA; Varypataki E; Sibuea S; Ossendorp F; Jiskoot W
    Vaccine; 2015 Feb; 33(7):847-54. PubMed ID: 25576216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses.
    Liu J; Liu X; Han Y; Zhang J; Liu D; Ma G; Li C; Liu L; Kong D
    ACS Appl Mater Interfaces; 2018 Sep; 10(37):30983-30993. PubMed ID: 30136844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
    Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
    Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.